Last updated: October 16, 2025
Sponsor: University of Michigan Rogel Cancer Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pelvic Cancer
Treatment
Non-Interventional Study
Clinical Study ID
NCT07219134
UMCC 2024.027
NCI-2025-03767
HUM00259510
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with pelvis or genitourinary (GU) cancer requiring standard of careradiotherapy treatment
All adults, defined as individuals of 18 years of age or greater
Radiotherapy treatment will be performed on the Varian Ethos radiotherapysystem
Ability to understand and the willingness to sign a written informed consent
Exclusion
Exclusion Criteria:
- Minors, defined as individuals less than 18 years of age
Pregnant or nursing female
Study Design
Total Participants: 30
Treatment Group(s): 1
Primary Treatment: Non-Interventional Study
Phase:
Study Start date:
June 06, 2025
Estimated Completion Date:
June 30, 2027
Connect with a study center
University of Michigan Comprehensive Cancer Center
Ann Arbor 4984247, Michigan 5001836 48109
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.